Diazepam and Paraldehyde for Treatment of Severe Delirium Tremens

A Controlled Trial

  1. W. LEIGH THOMPSON, M.D.;
  2. ALLEN D. JOHNSON, M.D.; and
  3. WILLIS L. MADDREY, M.D., F.A.C.P.
  1. OSLER MEDICAL HOUSESTAFF,
    Baltimore, Maryland

    Abstract

    Thirty-four patients with severe delirium tremens were allocated randomly to treatment with paraldehyde (10 ml rectally every 30 minutes) or diazepam (10 mg then 5 mg intravenously every 5 minutes) until they were calm but awake. Diazepam-treated patients became calm in one half the time needed to calm patients with paraldehyde. Half of the patients had delirium tremens in association with pneumonia, pancreatitis, or alcoholic hepatitis; these patients required twice as much paraldehyde or diazepam for initial calming as patients with delirium tremens alone. Maintenance of a calm state was accomplished easily with either diazepam, intramuscularly, or paraldehyde, rectally. Adverse reactions occurred in nine patients, all of whom had been treated with paraldehyde; these patients had greater degrees of fever, tachypnea, and tachycardia and required three times longer for initial calming than patients without adverse reactions. Diazepam given under this regimen is a safe and effective sedative for management of combative patients with severe delirium tremens.

    Article and Author Information

    • ▸From the Department of Medicine, School of Medicine, The Johns Hopkins University and Hospital, Baltimore, Maryland.

    • A preliminary abstract of this paper appeared in Clinical Research 19:357, 1971.

    • ▸Reprint requests should be addressed to W. Leigh Thompson, M.D., Department of Medicine, University Hospitals, Cleveland, OH 44106.

      • Received May 13, 1974.
      • Accepted November 8, 1974.
    « Previous | Next Article »Table of Contents